TY - JOUR
T1 - Ovarian sex cord-stromal tumors
AU - Schultz, Kris Ann P.
AU - Harris, Anne K.
AU - Schneider, Dominik T.
AU - Young, Robert H.
AU - Brown, Jubilee
AU - Gershenson, David M.
AU - Dehner, Louis P.
AU - Hill, D. Ashley
AU - Messinger, Yoav H.
AU - Frazier, A. Lindsay
N1 - Publisher Copyright:
© Copyright 2016 by American Society of Clinical Oncology.
PY - 2016/10
Y1 - 2016/10
N2 - Ovarian sex cord-stromal tumors are clinically significant heterogeneous tumors that include several pathologic types. These tumors are often found in adolescents and young adults and can present with hormonal manifestations as well as signs and symptoms of a pelvic mass. Serum tumor markers may assist in preoperative diagnosis and surveillance. Several subtypes are associated with genetic predisposition, including those observed in patients with Peutz-Jegher syndrome. Recent studies have elucidated the relationship between Sertoli-Leydig cell tumors and DICER1 mutations. When classified as International Federation of Gynecology and Obstetrics stage Ia, most subtypes may be treated with surgery alone. Higher stage or recurrent tumors have variable prognoses that range from a usually rapid course in poorly differentiated Sertoli-Leydig cell tumor to an often prolonged course in adult granulosa cell tumors. New understanding of the molecular pathogenesis of these tumors may pave the way for novel therapeutics.
AB - Ovarian sex cord-stromal tumors are clinically significant heterogeneous tumors that include several pathologic types. These tumors are often found in adolescents and young adults and can present with hormonal manifestations as well as signs and symptoms of a pelvic mass. Serum tumor markers may assist in preoperative diagnosis and surveillance. Several subtypes are associated with genetic predisposition, including those observed in patients with Peutz-Jegher syndrome. Recent studies have elucidated the relationship between Sertoli-Leydig cell tumors and DICER1 mutations. When classified as International Federation of Gynecology and Obstetrics stage Ia, most subtypes may be treated with surgery alone. Higher stage or recurrent tumors have variable prognoses that range from a usually rapid course in poorly differentiated Sertoli-Leydig cell tumor to an often prolonged course in adult granulosa cell tumors. New understanding of the molecular pathogenesis of these tumors may pave the way for novel therapeutics.
UR - http://www.scopus.com/inward/record.url?scp=84991225139&partnerID=8YFLogxK
U2 - 10.1200/JOP.2016.016261
DO - 10.1200/JOP.2016.016261
M3 - Review article
C2 - 27858560
AN - SCOPUS:84991225139
SN - 1554-7477
VL - 12
SP - 940
EP - 946
JO - Journal of Oncology Practice
JF - Journal of Oncology Practice
IS - 10
ER -